Commercial strategy

GlycaNova’s core technology is a proprietary production process which isolates undenatured beta-glucan from mushroom mycelia. Research has shown that GlycaNova beta-glucans are superior to denatured beta-glucans in their ability to enhance the immune system.

GlycaNova markets its consumer healthcare products, including Lentinex, Immuna and Ganodex, via a combination of distribution partners and direct sales. The Company is also developing products for animal health.

Please contact us in connection with potential distribution partnerships, licensing agreements or product development enquiries.